Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Non-Current Assets: 2021-2025

Historic Non-Current Assets for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $1.8 billion.

  • LifeStance Health's Non-Current Assets fell 177.54% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 billion, marking a year-over-year decrease of 305.83%. This contributed to the annual value of $1.8 billion for FY2024, which is 416.35% down from last year.
  • Per LifeStance Health's latest filing, its Non-Current Assets stood at $1.8 billion for Q3 2025, which was down 177.54% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, LifeStance Health's Non-Current Assets ranged from a high of $1.9 billion in Q1 2023 and a low of $1.6 billion during Q2 2021
  • Its 5-year average for Non-Current Assets is $1.8 billion, with a median of $1.8 billion in 2024.
  • Per our database at Business Quant, LifeStance Health's Non-Current Assets soared by 1686.5% in 2022 and then plummeted by 473.0% in 2024.
  • Over the past 5 years, LifeStance Health's Non-Current Assets (Quarter) stood at $1.7 billion in 2021, then grew by 16.87% to $1.9 billion in 2022, then decreased by 2.91% to $1.9 billion in 2023, then fell by 4.16% to $1.8 billion in 2024, then fell by 0.95% to $1.8 billion in 2025.
  • Its last three reported values are $1.8 billion in Q3 2025, $1.8 billion for Q2 2025, and $1.8 billion during Q1 2025.